• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

P-糖蛋白抑制剂地尔硫䓬类似物 8-(4-氯苯基)-5-甲基-8-[(2Z)-戊-2-烯-1-基氧基]-8H-[1,2,4]恶二唑[3,4-c][1,4]噻嗪-3-酮抑制酯酶活性和 H3 组蛋白乙酰化。

The P-glycoprotein inhibitor diltiazem-like 8-(4-chlorophenyl)-5-methyl-8-[(2Z)-pent-2-en-1-yloxy]-8H-[1,2,4]oxadiazolo[3,4-c][1,4]thiazin-3-one inhibits esterase activity and H3 histone acetylation.

机构信息

Department of Sciences, University of Basilicata, Via dell'Ateneo Lucano 10, Potenza, 85100, Italy.

Department of Chemistry "G. Ciamician", Alma Mater Studiorum-University of Bologna, Via F. Selmi 2, Bologna, 40126, Italy.

出版信息

Eur J Med Chem. 2019 Feb 15;164:1-7. doi: 10.1016/j.ejmech.2018.12.037. Epub 2018 Dec 17.

DOI:10.1016/j.ejmech.2018.12.037
PMID:30583246
Abstract

With the aim to reduce multidrug resistance several molecules were synthesized and tested for their ability to inhibit ATP-binding cassette (ABC) proteins, which are responsible for drugs transport out from cells. The compound 8-(4-chlorophenyl)-5-methyl-8-[(2Z)-pent-2-en-1-yloxy]-8H-[1,2,4]oxadiazolo[3,4-c][1,4]thiazin-3-one namely 2c, is structurally related to the myocardial-calcium-channel-modulator diltiazem and is considered one of the most efficient P-glycoprotein inhibitors, able to induce apoptosis at low concentrations of doxorubicin in multidrug resistant ovarian cells. In this study experiments were carried out to evaluate other biological activities of compound 2c. We verified the ability of 2c to inhibit ABC transporters do not involved in drug resistance and considering the inhibitory effect of diltiazem on recombinant human carboxylesterase, we observed its inhibitory effect on the esterase activity. Our findings demonstrated that 2c exhibits broad-spectrum activity as ABC transporters inhibitor being able to inhibit ABCC6, a protein belonging to the ABC family although poorly involved in drug resistance. 2c also inhibits cell esterase activity, acetylcholine esterase activity in vitro and cell histone H3 acetylation according to its structural homology with some known HAT inhibitors. The results obtained provide new knowledge on the biological activities of 2c and represent useful information when it is used as an inhibitor of drug resistance.

摘要

为了降低多药耐药性,合成了几种分子,并测试了它们抑制三磷酸腺苷结合盒(ABC)蛋白的能力,ABC 蛋白负责将药物从细胞内排出。化合物 8-(4-氯苯基)-5-甲基-8-[(2Z)-戊-2-烯-1-氧基]-8H-[1,2,4]恶二唑[3,4-c][1,4]噻嗪-3-酮,即 2c,与心肌钙通道调节剂地尔硫卓在结构上有关,被认为是最有效的 P 糖蛋白抑制剂之一,能够在多药耐药卵巢细胞中低浓度阿霉素诱导细胞凋亡。在这项研究中,进行了实验以评估化合物 2c 的其他生物学活性。我们验证了 2c 抑制不涉及耐药性的 ABC 转运体的能力,并且考虑到地尔硫卓对重组人羧酸酯酶的抑制作用,我们观察了其对酯酶活性的抑制作用。我们的发现表明,2c 作为 ABC 转运体抑制剂具有广谱活性,能够抑制 ABCC6,一种属于 ABC 家族的蛋白,尽管其在耐药性方面的参与程度较低。2c 还抑制细胞酯酶活性、乙酰胆碱酯酶活性和细胞组蛋白 H3 乙酰化,这与其与一些已知的 HAT 抑制剂的结构同源性有关。所得结果提供了关于 2c 的生物学活性的新知识,并且在将其用作耐药性抑制剂时提供了有用的信息。

相似文献

1
The P-glycoprotein inhibitor diltiazem-like 8-(4-chlorophenyl)-5-methyl-8-[(2Z)-pent-2-en-1-yloxy]-8H-[1,2,4]oxadiazolo[3,4-c][1,4]thiazin-3-one inhibits esterase activity and H3 histone acetylation.P-糖蛋白抑制剂地尔硫䓬类似物 8-(4-氯苯基)-5-甲基-8-[(2Z)-戊-2-烯-1-基氧基]-8H-[1,2,4]恶二唑[3,4-c][1,4]噻嗪-3-酮抑制酯酶活性和 H3 组蛋白乙酰化。
Eur J Med Chem. 2019 Feb 15;164:1-7. doi: 10.1016/j.ejmech.2018.12.037. Epub 2018 Dec 17.
2
Inhibition of MDR1 activity and induction of apoptosis by analogues of nifedipine and diltiazem: an in vitro analysis.硝苯地平和地尔硫䓬类似物对 MDR1 活性的抑制作用和诱导细胞凋亡的作用:体外分析。
Invest New Drugs. 2011 Feb;29(1):98-109. doi: 10.1007/s10637-009-9340-7. Epub 2009 Oct 30.
3
9-Deazapurines as Broad-Spectrum Inhibitors of the ABC Transport Proteins P-Glycoprotein, Multidrug Resistance-Associated Protein 1, and Breast Cancer Resistance Protein.9-去氮杂嘌呤作为 ABC 转运蛋白 P-糖蛋白、多药耐药相关蛋白 1 和乳腺癌耐药蛋白的广谱抑制剂。
J Med Chem. 2017 Nov 9;60(21):8758-8780. doi: 10.1021/acs.jmedchem.7b00788. Epub 2017 Oct 26.
4
β-carotene reverses multidrug resistant cancer cells by selectively modulating human P-glycoprotein function.β-胡萝卜素通过选择性调节人 P-糖蛋白功能逆转多药耐药癌细胞。
Phytomedicine. 2016 Mar 15;23(3):316-23. doi: 10.1016/j.phymed.2016.01.008. Epub 2016 Feb 6.
5
Protein kinase C effectors bind to multidrug ABC transporters and inhibit their activity.蛋白激酶C效应物与多药ABC转运蛋白结合并抑制其活性。
Biochemistry. 2001 Feb 27;40(8):2564-71. doi: 10.1021/bi002453m.
6
Elacridar enhances the cytotoxic effects of sunitinib and prevents multidrug resistance in renal carcinoma cells.艾拉司群增强了舒尼替尼的细胞毒性作用,并防止肾癌细胞出现多药耐药。
Eur J Pharmacol. 2015 Jan 5;746:258-66. doi: 10.1016/j.ejphar.2014.11.021. Epub 2014 Nov 29.
7
High-throughput screening identifies Ceefourin 1 and Ceefourin 2 as highly selective inhibitors of multidrug resistance protein 4 (MRP4).高通量筛选确定Ceefourin 1和Ceefourin 2为多药耐药蛋白4(MRP4)的高选择性抑制剂。
Biochem Pharmacol. 2014 Sep 1;91(1):97-108. doi: 10.1016/j.bcp.2014.05.023. Epub 2014 Jun 25.
8
Inhibition of MDR1 activity in vitro by a novel class of diltiazem analogues: toward new candidates.一类新型地尔硫䓬类似物对多药耐药蛋白1(MDR1)活性的体外抑制作用:寻找新的候选药物
J Med Chem. 2009 Jan 22;52(2):259-66. doi: 10.1021/jm801195k.
9
HM30181 Derivatives as Novel Potent and Selective Inhibitors of the Breast Cancer Resistance Protein (BCRP/ABCG2).HM30181衍生物作为乳腺癌耐药蛋白(BCRP/ABCG2)新型强效选择性抑制剂
J Med Chem. 2015 May 14;58(9):3910-21. doi: 10.1021/acs.jmedchem.5b00188. Epub 2015 Apr 24.
10
Parguerenes: Marine red alga bromoditerpenes as inhibitors of P-glycoprotein (ABCB1) in multidrug resistant human cancer cells.派格来恩:海洋红藻溴二萜作为多药耐药性人类癌细胞中 P 糖蛋白(ABCB1)的抑制剂。
Biochem Pharmacol. 2013 May 1;85(9):1257-68. doi: 10.1016/j.bcp.2013.02.005. Epub 2013 Feb 13.

引用本文的文献

1
Structural and Functional Characterization of the ABCC6 Transporter in Hepatic Cells: Role on PXE, Cancer Therapy and Drug Resistance.ABCC6 转运蛋白在肝细胞中的结构与功能特征:在 PXE、癌症治疗和耐药性中的作用。
Int J Mol Sci. 2021 Mar 11;22(6):2858. doi: 10.3390/ijms22062858.
2
Inhibition of ABCC6 Transporter Modifies Cytoskeleton and Reduces Motility of HepG2 Cells via Purinergic Pathway.ABCC6 转运蛋白抑制剂通过嘌呤能途径改变 HepG2 细胞的细胞骨架并降低其迁移能力。
Cells. 2020 Jun 5;9(6):1410. doi: 10.3390/cells9061410.